Paolo Mulatero
Overview
Explore the profile of Paolo Mulatero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
4920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panarelli A, Schweizer J, R O L Schweizer J, Stufchen I, Stuefchen I, Brudgam D, et al.
Eur J Endocrinol
. 2025 Feb;
192(3):S15-S25.
PMID: 39965111
Context: Bilateral macronodular adrenal disease (BMAD) typically presents with bilateral benign adrenocortical macronodules and variable cortisol excess. Anecdotal evidence suggests oversecretion of other adrenal steroids, including mineralocorticoids. Hypothesis: We hypothesized...
2.
Monticone S, Goi J, Burrello J, Di Dalmazi G, Cicero A, Mancusi C, et al.
J Endocrinol Invest
. 2025 Jan;
PMID: 39826012
Purpose: The delayed or missed diagnosis of secondary hypertension contributes to the poor blood pressure control worldwide. This study aimed to assess the diagnostic approach to primary aldosteronism (PA) and...
3.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(2):119-133.
PMID: 39824204
Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment...
4.
Burrello J, Goi J, Burrello A, Vacchi E, Rendon-Angel A, Lazzarini E, et al.
NPJ Aging
. 2024 Dec;
10(1):63.
PMID: 39702460
Extracellular vesicles (EVs) offer valuable diagnostic and prognostic insights for cardiovascular (CV) diseases, but the influence of age-related chronic inflammation ("inflammaging") and sex differences on EV profiles linked to CV...
5.
Isaia G, Presta R, Brunetti E, Cacciatore C, Carbonara F, Berardo E, et al.
Clin Nutr ESPEN
. 2024 Oct;
64:221-228.
PMID: 39396703
Background & Aims: Malnutrition negatively affects the prognosis and quality of life of hospitalized patients. However, there are several gaps between evidence-based knowledge and current clinical practice. Our primary aim...
6.
Pappaccogli M, Ponsa L, Goi J, Burrello J, Di Dalmazi G, Cicero A, et al.
High Blood Press Cardiovasc Prev
. 2024 Sep;
31(5):501-512.
PMID: 39292380
Introduction: Renovascular hypertension (RVH) remains underdiagnosed despite its significant cardiovascular and renal morbidity. Aim: This survey investigated screening and management practices for RVH among hypertensive patients in Italian hypertension centres...
7.
Tetti M, Burrello J, Hureaux M, Billon C, Clauser E, Veglio F, et al.
Hypertension
. 2024 Sep;
81(11):2275-2285.
PMID: 39229746
Background: Hyperkalemia is a frequent electrolyte alteration whose prevalence varies widely, depending on the adopted cutoff, the setting (inpatients versus outpatients), and the characteristics of the study population. Familial hyperkalemic...
8.
Tetti M, Burrello J, Goi J, Parasiliti-Caprino M, Gioiello G, Settanni F, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39126022
Primary aldosteronism (PA) is the most common cause of endocrine arterial hypertension, and the suggested screening test for case detection is the aldosterone-to-renin ratio (ARR) or aldosterone-to-direct renin ratio (ADRR)...
9.
Araujo-Castro M, Ruiz-Sanchez J, Gonzalvo C, Lamas C, Parra Ramirez P, Martin Marcos-Rojas P, et al.
J Clin Endocrinol Metab
. 2024 Jul;
PMID: 39058909
Purpose: To determine the rate of genetic testing for familial hyperaldosteronism (FH) in the SPAIN-ALDO Registry and to describe the clinical characteristics of patients with FH. In addition, a literature...
10.
Mulatero P, Wuerzner G, Groessl M, Sconfienza E, Damianaki A, Forestiero V, et al.
EClinicalMedicine
. 2024 Apr;
71:102576.
PMID: 38618204
Background: Primary aldosteronism (PA) is caused by autonomous aldosterone overproduction and characterised by uncontrolled hypertension. There are currently no treatments that target aldosterone synthesis. We evaluated the safety and efficacy...